Soap (21 CFR 701.20)
Soap (21 CFR 701.20) is FDA's two-condition interpretation of the soap exclusion from the US cosmetic definition: composition and soap-only representation.

On this page · 4 sections
01Soap (21 CFR 701.20)
LAW — Soap, for FDA’s interpretation of the US statutory cosmetic exclusion, is an article meeting both conditions in 21 CFR 701.20(a). Neither composition alone nor calling a product “soap” establishes that it falls within this interpretation. The exact conditions are:
LAW — 701.20(a)(1): “(1) The bulk of the nonvolatile matter in the product consists of an alkali salt of fatty acids and the detergent properties of the article are due to the alkali-fatty acid compounds; and”
LAW — 701.20(a)(2): “(2) The product is labeled, sold, and represented only as soap.”
LAW — 21 U.S.C. 321(i) defines cosmetics to include articles intended for application to the human body for cleansing, beautifying, promoting attractiveness or altering appearance, and components of such articles, but expressly excludes soap. Section 701.20 supplies FDA’s interpretation of that exclusion; it does not replace the separate drug definition.
PRACTICE — Read condition (1) as two connected questions: what constitutes the bulk of the nonvolatile matter, and what provides the detergent properties? Review condition (2) across labels, sales materials and other representations, rather than checking only the product name.
02When a body cleanser is a cosmetic or a drug
LAW — Failure to meet either condition means an article intended for cleansing the human body falls under 701.20(b), which states: (b) Products intended for cleansing the human body and which are not “soap” as set out in paragraph (a) of this section are “cosmetics,” and accordingly they are subject to the requirements of the act and the regulations thereunder. For example, such a product in bar form is subject to the requirement, among others, that it shall bear a label containing an accurate statement of the weight of the bar in avoirdupois pounds and ounces, this statement to be prominently and conspicuously displayed so as to be likely to be read under the customary conditions of purchase and use.
LAW — The intended-use branches of 21 U.S.C. 321(g)(1) also matter. Clause (B) covers articles intended for diagnosis, cure, mitigation, treatment or prevention of disease; clause (C) covers articles other than food intended to affect body structure or function. A cleanser with such an intended use can be a drug. A cosmetic classification does not negate these separate criteria.
PRACTICE — Keep the composition assessment and intended-use assessment distinct. A reviewer should explain both why the soap conditions are or are not met and whether the documented intended use engages the drug definition.
03Worked comparison: fictional cleansing products
PRACTICE — All products and claims below are fictional. Quoted claims are assumed representations, not statements of efficacy. The manufacturer’s category conclusion is a qualified person’s documented decision applying the legal criteria to evidence, not an automatic result from this table or a product name.
PRACTICE — Fictional products, classification reasoning and review evidence
| Fictional product | Assumed facts and condition touched | Documented conclusion on those facts | Records the qualified person reviews |
|---|---|---|---|
| A: Soap-only bar | Both parts of 701.20(a)(1) are established. Labeled, sold and represented only as soap, satisfying (a)(2). | Within FDA’s soap interpretation and the 321(i) cosmetic exclusion; no drug intended use identified in the assumed record. | Current formulation, ingredient specifications, detergent-property rationale, label versions and sales representations. |
| B: Synthetic-detergent cleansing bar | Detergent properties come from synthetic detergents, not alkali-fatty acid compounds. Condition (a)(1) fails even if marketed as soap. | A body-cleansing cosmetic under 701.20(b). Bar form does not establish soap status. | Ingredient and formulation records, explanation of detergency, body-cleansing use description and bar label. |
| C: Soap-composition bar claiming “moisturizes skin” | Condition (a)(1) is established, but the added skin-moisturizing representation goes beyond soap-only presentation under (a)(2). | A body-cleansing cosmetic under 701.20(b) on these assumed facts. | Composition assessment, packaging, website copy and the exact moisturizing claim in context. |
| D: Body cleanser claiming “treats acne” | Not represented only as soap under (a)(2). The stated disease-treatment intended use also touches 321(g)(1)(B). | A cosmetic under 701.20(b) and also within the drug definition on the stated intended use. | Product identity, formulation, label, complete disease-claim wording and dated promotional materials. |
04Records supporting a documented category decision
PRACTICE — Keep a versioned decision file for a reviewer with relevant product and US regulatory knowledge. “Qualified person” here describes that practical role, not a prescribed appointment. The following is a suggested record set, not a recordkeeping duty created by the supplied excerpts:
- Product identity and intended use: identify the product, its form, the body-cleansing use and the version being assessed.
- Composition evidence: retain the applicable formulation and ingredient specifications, with an explanation addressing the bulk of the nonvolatile matter.
- Detergent-property rationale: document which compounds provide detergency and how that conclusion supports or fails condition (a)(1).
- Label history: retain dated packaging and label artwork, including the wording used to identify and describe the product.
- Claims inventory: preserve dated sales listings, website pages, advertisements and other representations, with their wording and context rather than isolated slogans.
- Decision note: identify the reviewer, date and evidence versions; address each soap condition, 701.20(b), and relevant drug intended use; record the conclusion, rationale and unresolved questions.
PRACTICE — Revisit the decision when composition, labeling, sales presentation or claims change. Preserve the earlier evidence and explain whether the change affects the reasoning, rather than carrying forward an old category without review.
Frequently asked questions
Q.Is a soap ingredient enough to qualify a cleanser as soap?+
LAW — No. Section 701.20(a)(1) addresses both the bulk of the nonvolatile matter and the source of detergent properties. Condition (a)(2), requiring soap-only labeling, sale and representation, must also be met.
Q.Can a soap-composition cleanser be a drug?+
LAW — Yes. Composition does not displace 321(g)(1): disease-related intended use or an intended effect on body structure or function can bring a cleanser within the drug definition.
Q.What if the records do not support a clear conclusion?+
PRACTICE — Record the evidence gap and refer the decision for further qualified review. Do not treat an ingredient name, bar shape or incomplete claims inventory as a substitute for a documented assessment.
Primary sources
Further reading
Want to see how Soap (21 CFR 701.20) could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.
